APOE and Mental deterioration: Rather than focus on the differences between APOE-ε4 carriers and non-carriers, we aim to determine the association among age, vascular diseases, plasma Aβ and cortical Aβ plaques in addition to how Aβ pathologies and vascular diseases predict longitudinal neurodegeneration and cognitive decline in APOE-ε4 carriers and non-carriers separately.